Format
Items per page
Sort by

Send to:

Choose Destination

Homo sapiens DNA, chromosome 8q23, forward end of BAC clone: KB1585C12, genomic survey sequence [Homo sapiens]

Search results

Items: 1 to 20 of 255

1.

Rho Kinase Inhibition as a Therapeutic for Progressive Supranuclear Palsy and Corticobasal Degeneration.

Gentry EG, Henderson BW, Arrant AE, Gearing M, Feng Y, Riddle NC, Herskowitz JH.

J Neurosci. 2016 Jan 27;36(4):1316-23. doi: 10.1523/JNEUROSCI.2336-15.2016.

PMID:
26818518
2.

A Meta-Analysis of Alzheimer's Disease Incidence and Prevalence Comparing African-Americans and Caucasians.

Steenland K, Goldstein FC, Levey A, Wharton W.

J Alzheimers Dis. 2015;50(1):71-6. doi: 10.3233/JAD-150778.

PMID:
26639973
3.

Progression of Extrapyramidal Signs in Alzheimer's Disease: Clinical and Neuropathological Correlates.

Tosto G, Monsell SE, Hawes SE, Bruno G, Mayeux R.

J Alzheimers Dis. 2015;49(4):1085-93. doi: 10.3233/JAD-150244.

PMID:
26599050
4.

Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer's disease.

Zhang Z, Song M, Liu X, Su Kang S, Duong DM, Seyfried NT, Cao X, Cheng L, Sun YE, Ping Yu S, Jia J, Levey AI, Ye K.

Nat Commun. 2015 Nov 9;6:8762. doi: 10.1038/ncomms9762.

5.

Presence of inclusions positive for polyglycine containing protein, FMRpolyG, indicates that repeat-associated non-AUG translation plays a role in fragile X-associated primary ovarian insufficiency.

Buijsen RA, Visser JA, Kramer P, Severijnen EA, Gearing M, Charlet-Berguerand N, Sherman SL, Berman RF, Willemsen R, Hukema RK.

Hum Reprod. 2016 Jan;31(1):158-68. doi: 10.1093/humrep/dev280. Epub 2015 Nov 3.

PMID:
26537920
6.

Antipsychotic Use in a Diverse Population With Dementia: A Retrospective Review of the National Alzheimer's Coordinating Center Database.

Xiong GL, Filshtein T, Beckett LA, Hinton L.

J Neuropsychiatry Clin Neurosci. 2015 Fall;27(4):326-32. doi: 10.1176/appi.neuropsych.15010020.

PMID:
26488486
7.

Patterns of effective connectivity during memory encoding and retrieval differ between patients with mild cognitive impairment and healthy older adults.

Hampstead BM, Khoshnoodi M, Yan W, Deshpande G, Sathian K.

Neuroimage. 2016 Jan 1;124(Pt A):997-1008. doi: 10.1016/j.neuroimage.2015.10.002. Epub 2015 Oct 13.

PMID:
26458520
8.

Interaction between variants in CLU and MS4A4E modulates Alzheimer's disease risk.

Ebbert MT, Boehme KL, Wadsworth ME, Staley LA; Alzheimer's Disease Neuroimaging Initiative; Alzheimer's Disease Genetics Consortium, Mukherjee S, Crane PK, Ridge PG, Kauwe JS.

Alzheimers Dement. 2016 Feb;12(2):121-9. doi: 10.1016/j.jalz.2015.08.163. Epub 2015 Oct 9.

PMID:
26449541
9.

Latent Classes of Neuropsychiatric Symptoms in NACC Controls and Conversion to Mild Cognitive Impairment or Dementia.

Leoutsakos JM, Forrester SN, Lyketsos CG, Smith GS.

J Alzheimers Dis. 2015;48(2):483-93. doi: 10.3233/JAD-150421.

10.

Prevalence of Traumatic Brain Injury in Early Versus Late-Onset Alzheimer's Disease.

Mendez MF, Paholpak P, Lin A, Zhang JY, Teng E.

J Alzheimers Dis. 2015;47(4):985-93. doi: 10.3233/JAD-143207.

11.

Modulation of Renin-Angiotensin System May Slow Conversion from Mild Cognitive Impairment to Alzheimer's Disease.

Wharton W, Goldstein FC, Zhao L, Steenland K, Levey AI, Hajjar I.

J Am Geriatr Soc. 2015 Sep;63(9):1749-56. doi: 10.1111/jgs.13627.

12.

Association Between Angiotensin Receptor Blockers and Longitudinal Decline in Tau in Mild Cognitive Impairment.

Hajjar I, Levey A.

JAMA Neurol. 2015 Sep;72(9):1069-70. doi: 10.1001/jamaneurol.2015.1001. No abstract available.

13.

Association of Long Runs of Homozygosity With Alzheimer Disease Among African American Individuals.

Ghani M, Reitz C, Cheng R, Vardarajan BN, Jun G, Sato C, Naj A, Rajbhandary R, Wang LS, Valladares O, Lin CF, Larson EB, Graff-Radford NR, Evans D, De Jager PL, Crane PK, Buxbaum JD, Murrell JR, Raj T, Ertekin-Taner N, Logue M, Baldwin CT, Green RC, Barnes LL, Cantwell LB, Fallin MD, Go RC, Griffith PA, Obisesan TO, Manly JJ, Lunetta KL, Kamboh MI, Lopez OL, Bennett DA, Hendrie H, Hall KS, Goate AM, Byrd GS, Kukull WA, Foroud TM, Haines JL, Farrer LA, Pericak-Vance MA, Lee JH, Schellenberg GD, St George-Hyslop P, Mayeux R, Rogaeva E; Alzheimer’s Disease Genetics Consortium.

JAMA Neurol. 2015 Nov;72(11):1313-23. doi: 10.1001/jamaneurol.2015.1700.

14.

Pattern of extrapyramidal signs in Alzheimer's disease.

Tosto G, Monsell SE, Hawes SE, Mayeux R.

J Neurol. 2015 Nov;262(11):2548-56. doi: 10.1007/s00415-015-7886-1. Epub 2015 Sep 4.

PMID:
26338814
15.

Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.

Monsell SE, Kukull WA, Roher AE, Maarouf CL, Serrano G, Beach TG, Caselli RJ, Montine TJ, Reiman EM.

JAMA Neurol. 2015 Oct;72(10):1124-31. doi: 10.1001/jamaneurol.2015.1721.

PMID:
26302353
16.

A retroactive spatial cue improved VSTM capacity in mild cognitive impairment and medial temporal lobe amnesia but not in healthy older adults.

Newsome RN, Duarte A, Pun C, Smith VM, Ferber S, Barense MD.

Neuropsychologia. 2015 Oct;77:148-57. doi: 10.1016/j.neuropsychologia.2015.08.017. Epub 2015 Aug 20.

PMID:
26300388
17.

Cerebral amyloid angiopathy and its co-occurrence with Alzheimer's disease and other cerebrovascular neuropathologic changes.

Brenowitz WD, Nelson PT, Besser LM, Heller KB, Kukull WA.

Neurobiol Aging. 2015 Oct;36(10):2702-8. doi: 10.1016/j.neurobiolaging.2015.06.028. Epub 2015 Jul 8.

PMID:
26239176
19.

Associations between Potentially Modifiable Risk Factors and Alzheimer Disease: A Mendelian Randomization Study.

Østergaard SD, Mukherjee S, Sharp SJ, Proitsi P, Lotta LA, Day F, Perry JR, Boehme KL, Walter S, Kauwe JS, Gibbons LE; Alzheimer’s Disease Genetics Consortium; GERAD1 Consortium; EPIC-InterAct Consortium, Larson EB, Powell JF, Langenberg C, Crane PK, Wareham NJ, Scott RA.

PLoS Med. 2015 Jun 16;12(6):e1001841; discussion e1001841. doi: 10.1371/journal.pmed.1001841. eCollection 2015 Jun.

20.

Genetically predicted body mass index and Alzheimer's disease-related phenotypes in three large samples: Mendelian randomization analyses.

Mukherjee S, Walter S, Kauwe JS, Saykin AJ, Bennett DA, Larson EB, Crane PK, Glymour MM; Adult Changes in Thought Study Investigators; Religious Orders Study/Memory and Aging Project Investigators; Alzheimer's Disease Genetics Consortium.

Alzheimers Dement. 2015 Dec;11(12):1439-51. doi: 10.1016/j.jalz.2015.05.015. Epub 2015 Jun 12.

PMID:
26079416
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk